Inflammasome Therapeutics
Phase 1Inflammasome Therapeutics is a science-based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration and type 2 diabetes.
Founded
2016
Focus
Drug DeliverySmall Molecules
About
Inflammasome Therapeutics is a science-based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration and type 2 diabetes.
Funding History
3Total raised: $150M
Series B$100MUndisclosedJun 15, 2020
Series A$40MUndisclosedJun 15, 2018
Seed$10MUndisclosedJun 15, 2016
Company Info
TypePrivate
Founded2016
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile